These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil. Sommariva D, Branchi A, Pini C, Scandiani L, Orlandi S, Fasoli A. Int J Clin Pharmacol Res; 1988 Dec 16; 8(5):383-92. PubMed ID: 3068163 [Abstract] [Full Text] [Related]
31. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. N Engl J Med; 1999 Aug 05; 341(6):410-8. PubMed ID: 10438259 [Abstract] [Full Text] [Related]
32. Risk factors for coronary artery disease in patients with acute myocardial infarction. Effects of age, sex and ethnicity. Eisenberg S, Ehrenfeld M, Friedman G, Friedlander Y. Isr J Med Sci; 1981 May 05; 17(5):309-17. PubMed ID: 7263187 [Abstract] [Full Text] [Related]